# BTAI (BioXcel Therapeutics, Inc.) - SEC EDGAR Financial Statements

> BioXcel Therapeutics, Inc. reported $742K in revenue and a net loss of $70.86M for the trailing twelve months ended June 30, 2026 (up 51.7% year over year), with a 53.1% gross margin and a -6054.7% operating margin.

- Canonical: https://convexityos.com/fundamentals/BTAI
- Markdown: https://convexityos.com/fundamentals/BTAI.md
- SEC CIK: 0001720893
- Reporting currency: USD
- Latest filing period: June 30, 2026
- Last synced: Nov 21, 2026, 05:11 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001720893&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | TTM | $742K | +51.7% YoY |
| Operating Income | TTM | -$44.93M | -6054.7% margin |
| Net Income | TTM | -$70.86M | -9549.9% net margin |
| Diluted EPS | TTM | -$2.34 | Split-adjusted |
| Free Cash Flow | TTM | -$50.90M | -6860.4% FCF margin |
| Cash & ST Investments | Jun 30, 2026 | $12.84M | Total debt: $104.5M |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $642K | $2.27M | $1.38M | $375K | -- | -- | -- | -- | -- |
| Cost of Revenue | $164K | $2.14M | $1.26M | $20K | -- | -- | -- | -- | -- |
| **Gross Profit** | $478K | $123K | $120K | $355K | -- | -- | -- | -- | -- |
| Research & Development | $30.25M | $30.43M | $84.33M | $91.24M | $52.71M | $57.99M | $25.80M | $14.56M | $2.69M |
| Selling, General & Admin | $20.49M | $34.49M | $83.41M | $68.76M | $54.23M | -- | -- | -- | -- |
| Total Operating Expenses | -- | -- | -- | -- | $106.9M | $82.30M | $33.60M | $19.96M | $4.54M |
| **Operating Income** | -$50.46M | -$67.25M | -$171.8M | -$159.6M | -$106.9M | -$82.30M | -$33.60M | -$19.96M | -$4.54M |
| **EBITDA** | -$50.16M | -$66.94M | -$171.5M | -$159.3M | -$106.6M | -$82.11M | -$33.45M | -$19.95M | -$4.54M |
| Interest Income | $1.07M | $2.60M | $5.65M | $2.53M | $44K | $155K | -- | -- | -- |
| Interest Expense | $16.98M | $15.13M | $13.31M | $8.21M | $40K | $27K | $20K | -- | -- |
| Income Tax Expense | $0 | $0 | $0 | -- | -- | -- | -- | -- | -- |
| **Net Income** | -$69.90M | -$59.60M | -$179.1M | -$165.8M | -$106.9M | -$82.17M | -$32.97M | -$19.27M | -$4.54M |
| Basic EPS | -$5.73 | -$23.51 | -$98.33 | -$94.72 | -$64.80 | -$60.64 | -$32.32 | -$21.12 | -$7.52 |
| **Diluted EPS** | -$5.73 | -$23.51 | -$98.33 | -$94.72 | -$64.80 | -$60.64 | -$32.32 | -$21.12 | -$7.52 |
| Basic Shares Outstanding | 12.2M | 2.5M | 1.8M | 1.8M | 1.6M | 1.4M | 1.0M | 910.7K | 605.3K |
| Diluted Shares Outstanding | 12.2M | 2.5M | 1.8M | 1.8M | 1.6M | 1.4M | 1.0M | 910.7K | 605.3K |

### Income Statement (Quarterly)

| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $182K | $206K | $256K | $98K | $120K | $168K | $366K | $214K |
| Cost of Revenue | $22K | $283K | $32K | $11K | $107K | $14K | $832K | $1.17M |
| **Gross Profit** | $160K | -$77K | $224K | $87K | $13K | $154K | -$466K | -$956K |
| Research & Development | $3.16M | $2.96M | $6.70M | $8.74M | $10.26M | $4.55M | $5.90M | $5.10M |
| Selling, General & Admin | $7.19M | $7.19M | $3.81M | $5.38M | $5.61M | $5.70M | $4.09M | $7.68M |
| **Operating Income** | -$10.19M | -$10.22M | -$10.28M | -$14.23M | -$15.85M | -$10.10M | -$10.49M | -$15.29M |
| **EBITDA** | -$10.18M | -$10.16M | -$10.21M | -$14.15M | -$15.78M | -$10.02M | -$10.42M | -$15.22M |
| Interest Income | $131K | $211K | $321K | $236K | $230K | $279K | $368K | $616K |
| Interest Expense | $4.26M | $4.20M | $4.40M | $4.37M | $4.22M | $3.99M | $4.03M | $3.79M |
| **Net Income** | -$14.71M | -$12.69M | -$12.54M | -$30.91M | -$19.19M | -$7.25M | -$10.86M | -$13.65M |
| Basic EPS | -$0.49 | -$0.54 | -- | -$2.18 | -$2.45 | -$1.50 | -- | -$5.15 |
| **Diluted EPS** | -$0.49 | -$0.54 | -- | -$2.18 | -$2.45 | -$1.50 | -- | -$5.15 |
| Basic Shares Outstanding | 30.3M | 23.6M | -- | 14.2M | 7.8M | 4.8M | -- | 2.6M |
| Diluted Shares Outstanding | 30.3M | 23.6M | -- | 14.2M | 7.8M | 4.8M | -- | 2.6M |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $28.41M | $29.85M | $65.22M | $193.7M | $233.0M | $213.1M | $32.43M | $42.56M | $887K |
| **Cash & Short-Term Investments** | $28.41M | $29.85M | $65.22M | $193.7M | $233.0M | $213.1M | $32.43M | $42.56M | $887K |
| Accounts Receivable, Net | $233K | $131K | $71K | $248K | -- | -- | -- | -- | -- |
| Inventory | $722K | $679K | $1.99M | $1.99M | -- | -- | -- | -- | -- |
| Other Current Assets | $10.95M | $1.44M | $2.08M | $3.84M | $956K | $984K | -- | -- | -- |
| **Total Current Assets** | $44.69M | $37.39M | $72.14M | $202.9M | $236.8M | $217.1M | $34.11M | $43.17M | $890K |
| Property, Plant & Equipment, Net | $175K | $475K | $784K | $1.08M | $1.29M | $1.27M | $1.04M | $327K | $4.0K |
| Other Non-Current Assets | $0 | $87K | $87K | $925K | $86K | $87K | $51K | $51K | -- |
| **Total Non-Current Assets** | $231K | $944K | $1.56M | $2.98M | $2.63M | $2.87M | $2.29M | $378K | $465K |
| **Total Assets** | $44.92M | $38.34M | $73.70M | $205.9M | $239.4M | $219.9M | $36.39M | $43.55M | $1.35M |
| Accounts Payable | $14.70M | $15.99M | $13.65M | $10.23M | $4.68M | $3.98M | $4.95M | $1.60M | $444K |
| Short-Term Debt | $24.93M | $0 | -- | -- | -- | -- | -- | -- | -- |
| Other Current Liabilities | -- | -- | -- | $404K | $293K | $237K | $331K | -- | -- |
| **Total Current Liabilities** | $53.93M | $22.23M | $27.27M | $32.90M | $16.67M | $11.84M | $8.47M | $4.66M | $2.34M |
| Long-Term Debt | $84.66M | $102.5M | $100.6M | $93.05M | -- | -- | -- | -- | -- |
| **Total Non-Current Liabilities** | $86.45M | $109.2M | $102.9M | $96.18M | $1.10M | $1.40M | $1.03M | $0 | $0 |
| **Total Liabilities** | $140.4M | $131.4M | $130.2M | $129.1M | $17.77M | $13.24M | $9.50M | $4.66M | $2.34M |
| **Total Debt (incl. Leases)** | $109.7M | $102.9M | $101.4M | $94.16M | $1.40M | $1.64M | $1.19M | -- | -- |
| Common Stock | $76K | $49K | $30K | $28K | $28K | $24K | $18K | $16K | $10K |
| Retained Earnings | -$720.1M | -$650.2M | -$590.6M | -$411.5M | -$245.8M | -$138.9M | -$56.69M | -$23.72M | -$4.45M |
| **Total Stockholders' Equity** | -$95.46M | -$93.10M | -$56.51M | $76.78M | $221.7M | $206.7M | $26.89M | $38.89M | -$982K |
| Total Equity | -$95.46M | -$93.10M | -$56.51M | $76.78M | $221.7M | $206.7M | $26.89M | $38.89M | -$982K |

### Balance Sheet (Quarterly)

| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $12.84M | $17.18M | $28.41M | $36.18M | $17.43M | $31.01M | $29.85M | $40.39M |
| **Cash & Short-Term Investments** | $12.84M | $17.18M | $28.41M | $36.18M | $17.43M | $31.01M | $29.85M | $40.39M |
| Accounts Receivable, Net | $82K | $216K | $233K | $0 | $17K | -- | $131K | $3.0K |
| Inventory | $483K | $500K | $722K | $459K | $506K | $642K | $679K | $1.52M |
| Other Current Assets | $11.26M | $12.07M | $10.95M | $934K | $995K | $1.39M | $1.44M | $1.40M |
| **Total Current Assets** | $28.70M | $33.91M | $44.69M | $44.40M | $25.24M | $37.78M | $37.39M | $47.79M |
| Property, Plant & Equipment, Net | $99K | $117K | $175K | $249K | $324K | $399K | $475K | $552K |
| Other Non-Current Assets | -- | -- | $0 | $0 | -- | $87K | $87K | $87K |
| **Total Non-Current Assets** | $99K | $117K | $231K | $389K | $546K | $789K | $944K | $1.10M |
| **Total Assets** | $28.80M | $34.02M | $44.92M | $44.79M | $25.79M | $38.57M | $38.34M | $48.89M |
| Accounts Payable | $18.78M | $16.25M | $14.70M | $16.28M | $16.69M | $15.45M | $15.99M | $14.89M |
| Short-Term Debt | $104.5M | $22.43M | $24.93M | $16.82M | $11.22M | $5.61M | $0 | -- |
| **Total Current Liabilities** | $137.1M | $54.99M | $53.93M | $37.80M | $33.38M | $25.55M | $22.23M | $25.56M |
| Long-Term Debt | $0 | $77.86M | $84.66M | $92.30M | $97.47M | $99.92M | $102.5M | $104.4M |
| **Total Non-Current Liabilities** | $7.11M | $84.57M | $86.45M | $95.91M | $100.1M | $103.2M | $109.2M | $109.0M |
| **Total Liabilities** | $144.3M | $139.6M | $140.4M | $133.7M | $133.5M | $128.7M | $131.4M | $134.5M |
| **Total Debt (incl. Leases)** | $104.5M | $100.3M | $109.7M | $109.3M | $108.9M | $105.9M | $102.9M | $105.0M |
| Common Stock | $31K | $27K | $76K | $73K | $60K | $59K | $49K | $42K |
| Retained Earnings | -$747.5M | -$732.8M | -$720.1M | -$707.5M | -$676.6M | -$657.5M | -$650.2M | -$639.3M |
| **Total Stockholders' Equity** | -$115.5M | -$105.5M | -$95.46M | -$88.92M | -$107.7M | -$90.17M | -$93.10M | -$85.63M |
| Total Equity | -$115.5M | -$105.5M | -$95.46M | -$88.92M | -$107.7M | -$90.17M | -$93.10M | -$85.63M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$69.90M | -$59.60M | -$179.1M | -$165.8M | -$106.9M | -$82.17M | -$32.97M | -$19.27M | -$4.54M |
| Depreciation & Amortization | $300K | $309K | $318K | $327K | $297K | $188K | $156K | $17K | $1.0K |
| Stock-Based Compensation | $2.77M | $6.16M | $18.61M | $17.34M | $19.45M | $14.61M | $3.14M | $3.08M | $1.61M |
| Change in Inventory | -$43K | $1.31M | -$6.0K | -$1.99M | -- | -- | -- | -- | -- |
| **Operating Cash Flow** | -$57.62M | -$72.03M | -$155.0M | -$135.3M | -$82.15M | -$66.35M | -$27.10M | -$13.51M | -$2.20M |
| Capital Expenditure | $0 | $0 | -$20K | -$139K | -$445K | -$316K | -$870K | -$340K | -- |
| **Free Cash Flow** | -$57.62M | -$72.03M | -$155.0M | -$135.5M | -$82.60M | -$66.67M | -$27.97M | -$13.85M | -- |
| **Investing Cash Flow** | $0 | $0 | -$20K | -$139K | -$445K | -$316K | -$870K | -$340K | -- |
| Common Stock Issued | $58.14M | $39.69M | $27.03M | -- | $101.0M | $255.8M | $17.81M | $56.51M | $2.06M |
| Share Repurchases | -- | -- | -- | -- | -- | -$9.02M | -- | -- | -- |
| **Financing Cash Flow** | $56.52M | $36.66M | $26.52M | $96.24M | $102.4M | $247.4M | $17.83M | $55.53M | $3.08M |
| **Net Change in Cash** | -$1.10M | -$35.37M | -$128.5M | -$39.24M | $19.85M | $180.7M | -$10.14M | $41.68M | $887K |

### Cash Flow Statement (Quarterly)

| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$14.71M | -$12.69M | -$12.54M | -$30.91M | -$19.19M | -$7.25M | -$10.86M | -$13.65M |
| Depreciation & Amortization | $18K | $58K | $74K | $75K | $75K | $76K | $77K | $77K |
| Stock-Based Compensation | $358K | $435K | $450K | $581K | $1.56M | $180K | -$199K | $1.86M |
| Change in Inventory | $17K | $222K | -$263K | $47K | $136K | $37K | $846K | $1.16M |
| **Operating Cash Flow** | -$6.10M | -$11.81M | -$14.21M | -$18.79M | -$12.57M | -$12.04M | -$14.81M | -$16.34M |
| Capital Expenditure | $0 | $0 | $0 | $0 | $0 | $0 | -- | -- |
| **Free Cash Flow** | -$6.10M | -$11.81M | -$14.21M | -$18.79M | -$12.57M | -$12.04M | -- | -- |
| **Investing Cash Flow** | $0 | $0 | $0 | $0 | $0 | $0 | -- | -- |
| Common Stock Issued | $3.11M | $8.50M | $5.76M | $38.23M | $140K | $14.01M | -- | $467K |
| **Financing Cash Flow** | $2.72M | $232K | $5.65M | $37.53M | $137K | $13.20M | $4.28M | $454K |
| **Net Change in Cash** | -$3.38M | -$11.58M | -$8.56M | $18.75M | -$12.44M | $1.16M | -$10.53M | -$15.88M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Gross Margin** | 74.5% | 5.4% | 8.7% | 94.7% | -- | -- | -- | -- | -- |
| **Operating Margin** | -7860.0% | -2967.6% | -12448.0% | -42572.0% | -- | -- | -- | -- | -- |
| **Net Profit Margin** | -10887.4% | -2630.1% | -12974.9% | -44201.9% | -- | -- | -- | -- | -- |
| Return on Equity (ROE) | -- | -- | -- | -215.9% | -48.2% | -39.8% | -122.6% | -49.6% | -- |
| Return on Assets (ROA) | -155.6% | -155.5% | -242.9% | -80.5% | -44.7% | -37.4% | -90.6% | -44.2% | -335.0% |
| Current Ratio | 0.83x | 1.68x | 2.65x | 6.17x | 14.21x | 18.33x | 4.03x | 9.26x | 0.38x |
| Quick Ratio | 0.82x | 1.65x | 2.57x | 6.11x | 13.98x | 18.00x | 3.83x | 9.13x | 0.38x |
| Debt to Equity | -- | -- | -- | 1.23x | 0.01x | 0.01x | 0.04x | -- | -- |
| **Revenue Growth (YoY)** | -71.7% | +64.2% | +268.0% | -- | -- | -- | -- | -- | -- |
| Gross Profit Growth (YoY) | +288.6% | +2.5% | -66.2% | -- | -- | -- | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Gross Margin** | 53.1% | 36.3% | 74.5% | -28.2% | -144.6% | -12.2% | 5.4% | 11.0% |
| **Operating Margin** | -6054.7% | -7439.0% | -7860.0% | -6738.3% | -5960.5% | -2871.5% | -2967.6% | -3366.7% |
| **Net Profit Margin** | -9549.9% | -11078.5% | -10887.4% | -9070.6% | -5869.8% | -2163.2% | -2630.1% | -3119.3% |
| Return on Assets (ROA) | -246.1% | -221.4% | -155.6% | -152.3% | -197.6% | -103.9% | -155.5% | -145.2% |
| Current Ratio | 0.21x | 0.62x | 0.83x | 1.17x | 0.76x | 1.48x | 1.68x | 1.87x |
| Quick Ratio | 0.21x | 0.61x | 0.82x | 1.16x | 0.74x | 1.45x | 1.65x | 1.81x |
| **Revenue Growth (YoY)** | +51.7% | +22.6% | -30.1% | -54.2% | -89.1% | -71.1% | -2.7% | -37.2% |
| Gross Profit Growth (YoY) | +1130.8% | -150.0% | -- | -- | -98.8% | -69.3% | -- | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
